A comparison of depot and oral atypical antipsychotics in terms of metabolic syndrome markers

Aykut, EVRİM; Karaguzel, Evrim

doi:10.1080/24750573.2017.1414575

A comparison of depot and oral atypical antipsychotics in terms of metabolic syndrome markers

Atıf İçin Kopyala

Aykut D. S., Karaguzel E. O.

PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, cilt.28, sa.3, ss.285-290, 2018 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 28 Sayı: 3
Basım Tarihi: 2018
Doi Numarası: 10.1080/24750573.2017.1414575
Dergi Adı: PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.285-290
Karadeniz Teknik Üniversitesi Adresli: Evet

Özet

OBJECTIVES: The duration of life of patients with schizophrenia is shorter than that of the general population for various reasons. Especially cardiovascular diseases are one of the most important causes of death in patients with schizophrenia. Our aim in this study is comparison of second-generation depot antipsychotics and second-generation oral antipsychotics used in the treatment of patients with schizophrenia in terms of metabolic syndrome criteria.